SISTEMA RENINA-ANGIOTENSINA-ALDOSTERONA Y COVID-19

Renin-angiotensin system at the heart of COVID-19 pandemic.

Biochimie. 2020 Apr 16;174:30-33.

https://doi-org.pbidi.unam.mx:2443/10.1016/j.biochi.2020.04.008

https://www-sciencedirect-com.pbidi.unam.mx:2443/science/article/pii/S030090842030078X?via%3Dihub

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19.

N Engl J Med. 2020 Apr 23;382(17):1653-1659.

https://doi-org.pbidi.unam.mx:2443/10.1056/NEJMsr2005760

https://www-nejm-org.pbidi.unam.mx:2443/doi/full/10.1056/NEJMsr2005760?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed

Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.

Drug Dev Res. 2020 Mar 4.

https://doi-org.pbidi.unam.mx:2443/10.1002/ddr.21656

https://onlinelibrary-wiley-com.pbidi.unam.mx:2443/doi/full/10.1002/ddr.21656

Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic.

Nat Rev Nephrol. 2020 Apr 3.

https://doi.org/10.1038/s41581-020-0279-4

https://www-nature-com.pbidi.unam.mx:2443/articles/s41581-020-0279-4

Might renin–angiotensin system blockers play a role in the COVID-19 pandemic?

Eur Heart J Cardiovasc Pharmacother. 2020 Apr 14. pii: pvaa030

https://doi-org.pbidi.unam.mx:2443/10.1093/ehjcvp/pvaa030

https://academic-oup-com.pbidi.unam.mx:2443/ehjcvp/advance-article/doi/10.1093/ehjcvp/pvaa030/5819835

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.

J Virol. 2020 Mar 17;94(7). pii: e00127-20

https://doi.org/10.1128/JVI.00127-20

https://jvi-asm-org.pbidi.unam.mx:2443/content/94/7/e00127-20.long

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

Cell 181, 1–10, April 16, 2020.

https://doi.org/10.1016/j.cell.2020.02.052

https://www-sciencedirect-com.pbidi.unam.mx:2443/science/article/pii/S0092867420302294?via%3Dihub

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.

Science. 2020 Mar 27;367(6485):1444-1448

doi: 10.1126/science.abb2762

https://dx-doi-org.pbidi.unam.mx:2443/10.1126%2Fscience.abb2762

https://science-sciencemag-org.pbidi.unam.mx:2443/content/367/6485/1444.long

Risks of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence.

Clin Pharmacol Ther. 2020 Apr 22.

https://doi-org.pbidi.unam.mx:2443/10.1002/cpt.1863

https://ascpt-onlinelibrary-wiley-com.pbidi.unam.mx:2443/doi/abs/10.1002/cpt.1863

Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications.

Cardiovasc Res. 2020 Apr 17.

https://doi-org.pbidi.unam.mx:2443/10.1093/cvr/cvaa096

https://academic-oup-com.pbidi.unam.mx:2443/cardiovascres/advance-article/doi/10.1093/cvr/cvaa096/5821240

Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension.

High Blood Press Cardiovasc Prev. 2020 Apr;27(2):105-108.

https://doi.org/10.1007/s40292-020-00380-3

https://link-springer-com.pbidi.unam.mx:2443/article/10.1007%2Fs40292-020-00380-3

Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients.

Elife. 2020 Apr 6;9. pii: e57278.

doi: 10.7554/eLife.57278

https://elifesciences.org/articles/57278

Comentarios desactivados en SISTEMA RENINA-ANGIOTENSINA-ALDOSTERONA Y COVID-19